CML. Reverse transcriptase polymerase chain reaction (RT-PCR) of the patient at diagnosis detects BCR/ABL with a b2a2 breakpoint. Control RNA lanes and b2a2/b3a2 lanes are labeled in the blot. Patient sample is marked by the large arrow (Courtesy Lorna Barnett and Richard O'Reilly, MSKCC).